AGMAVET
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 18 Jul 2023)
What this means for you
Registered since 09 Jan 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 09 Jan 2028: the §8 & §9 renewal).
Record
- Serial number
- 87483703
- Registration number
- 5374959
- Mark type
- Word mark
- Filed
- 11 Jun 2017
- Published for opposition
- 24 Oct 2017
- Registered
- 09 Jan 2018
- Next maintenance filing
- §8 & §9 renewal, due by 09 Jan 2028 (grace period to 09 Jul 2028)
Goods and services
- Class 005 — Pharmaceuticals: Analgesic and muscle relaxant pharmaceutical preparations; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed supplements; Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-epileptic pharmaceutical preparations; Anticonvulsants; Antidepressants; Chemotherapeutics; Clinical medical reagents; Dermatological pharmaceutical products; Dietary and nutritional supplements; Dietary and nutritional supplements containing agmatine; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement beverage for aiding nerve health; Dietary supplemental drinks; Dietary supplements; Dietary supplements also containing agmatine; Dietary supplements consisting primarily of agmatine; Dietary supplements for animals; Dietary supplements for human consumption; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Dietary supplements for treating nerve damage; Feed supplements for pets; Food supplements; Food supplements for treating nerve damage; Gels, creams and solutions for dermatological use; Glaucoma agents; Health food supplements; Homeopathic pharmaceuticals for use in the treatment of neuropathy; Homeopathic supplements; Medicaments for promoting recovery from nerve injury; Medicated animal feed; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated lotions for treating dermatological conditions; Medicated skin care preparations; Medicated supplements for foodstuffs for animals; Medicinal creams for skin care; Medicinal preparations for neuropathy; Natural dietary supplements; Natural supplements for treating depression and anxiety; Non-medicated additives for animal feed for use as nutritional supplements; Nutraceuticals for the treatment of neuropathy; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for promoting nerve health; Nutritional and dietary supplements formed and packaged as bars; Nutritional drinks for animals; Nutritional supplements; Nutritional supplements consisting primarily of agmatine; Nutritional supplements for promoting healthy nerves; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the form of capsules; Nutritional supplements in the nature of nutritionally fortified soft chews; Ocular pharmaceuticals; Oral analgesics; Pain relief medication; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparation for skin care; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of neuropathy; Pharmaceutical preparations for the treatment and prevention of neuropathy; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of neuropathy; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for neuropathy; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, elixirs for the treatment of neuropathy; Pharmaceutical products for skin care for animals; Pharmaceuticals, namely, psychotropics; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Preparation for the relief of pain; Psychotropics; Syrups for pharmaceutical purposes for the treatment of neuropathy; Therapeutic pharmaceutical for the treatment of neuropathy; Topical analgesic creams; Veterinary preparations for dog neuropathy; Veterinary preparations, namely, pain relief medication; Vitamins and dietary food supplements for animals
Owner
- Gilad Varda, Henderson, NV, US
- Gilad Varda, Henderson, NV, US
- Gilad Varda, Henderson, NV, US
- Gilad Gad, Henderson, NV, US
- Gilad Gad, Henderson, NV, US
- Gilad Gad, Henderson, NV, US
Prosecution history
- 18 Jul 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Jul 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Jan 2023 — TEAS SECTION 8 & 15 RECEIVED
- 09 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 24 Oct 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Oct 2017 — PUBLISHED FOR OPPOSITION
- 04 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Sept 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Sept 2017 — ASSIGNED TO EXAMINER
- 16 Jun 2017 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jun 2017 — NEW APPLICATION ENTERED